Mercer International Inc. (NASDAQ:MERC – Get Free Report) (TSE:MRI.U) major shareholder Peter Kellogg acquired 105,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The stock was acquired at an average price of $0.97 per share, with a total value of $101,850.00. Following the completion of the acquisition, the insider directly owned 1,957,000 shares of the company’s stock, valued at $1,898,290. This represents a 5.67% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Mercer International Stock Up 7.3%
NASDAQ:MERC traded up $0.07 during trading hours on Wednesday, reaching $1.05. The company’s stock had a trading volume of 294,682 shares, compared to its average volume of 598,459. The company has a market cap of $70.00 million, a price-to-earnings ratio of -0.13 and a beta of 0.53. Mercer International Inc. has a one year low of $0.75 and a one year high of $4.47. The business’s 50-day moving average is $1.22 and its 200-day moving average is $1.71. The company has a debt-to-equity ratio of 23.58, a current ratio of 2.17 and a quick ratio of 1.22.
Mercer International (NASDAQ:MERC – Get Free Report) (TSE:MRI.U) last issued its quarterly earnings data on Thursday, May 7th. The basic materials company reported ($0.78) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.74) by ($0.04). The business had revenue of $489.30 million during the quarter, compared to the consensus estimate of $493.00 million. Mercer International had a negative return on equity of 136.20% and a negative net margin of 28.51%. Equities research analysts predict that Mercer International Inc. will post -2.21 EPS for the current year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on MERC shares. TD Cowen cut shares of Mercer International from a “hold” rating to a “sell” rating and upped their price objective for the stock from $2.00 to $2.25 in a report on Wednesday, January 21st. TD Securities lowered shares of Mercer International from a “hold” rating to a “strong sell” rating in a research report on Wednesday, February 18th. Royal Bank Of Canada cut their target price on shares of Mercer International from $1.25 to $1.00 and set a “sector perform” rating for the company in a research report on Monday, May 11th. TD cut their target price on shares of Mercer International from $1.00 to $0.50 and set a “sell” rating for the company in a research report on Monday, May 11th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Mercer International in a research report on Friday, March 27th. Two analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Mercer International has an average rating of “Strong Sell” and a consensus target price of $1.85.
Get Our Latest Analysis on MERC
Mercer International Company Profile
Mercer International Inc is a publicly traded pulp producer headquartered in Vancouver, British Columbia. Listed on the NASDAQ under the symbol MERC, the company specializes in the manufacture of Northern Bleached Softwood Kraft (NBSK) pulp and dissolving pulp for use in tissue, specialty paper and textile applications.
Mercer’s core business activities include the operation of integrated pulp mills in North America and Europe. Its production portfolio encompasses NBSK pulp, renowned for its strength and versatility, and dissolving pulp, which serves as a key raw material in the manufacture of viscose, cellulose acetate and other specialty products.
The company’s facilities are located in British Columbia and the U.S.
Featured Articles
- Five stocks we like better than Mercer International
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
- The Great AI Rotation: Cashing In on Data
- Mirum Pharma: A Rare Disease Growth Story to Watch
- The Great Cloud Divide: How AI Is Reshuffling the Software Deck
Receive News & Ratings for Mercer International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mercer International and related companies with MarketBeat.com's FREE daily email newsletter.
